Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that metformin, a widely used anti-diabetic drug, may be useful in the prevention and treatment of different cancers. In the present study, we demonstrate that metformin directly inhibits the enzymatic function of hexokinase (HK) I and II in a cell line of triple-negative breast cancer (MDA-MB-231). The inhibition is selective for these isoforms, as documented by experiments with purified HK I and II as well as with cell lysates. Measurements of (18)F-fluoro-deoxyglycose uptake document that it is dose- and time-dependent and powerful enough to virtually abolish glucose consumption despite unchanged availability of membrane glucose transporters. The profound energetic imbalance activates phosphorylation and is subsequently followed by cell death. More importantly, the "in vivo" relevance of this effect is confirmed by studies of orthotopic xenografts of MDA-MB-231 cells in athymic (nu/nu) mice. Administration of high drug doses after tumor development caused an evident tumor necrosis in a time as short as 48 h. On the other hand, 1 mo metformin treatment markedly reduced cancer glucose consumption and growth. Taken together, our results strongly suggest that HK inhibition contributes to metformin therapeutic and preventive potential in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“However, experimental evidence pointed out that it can also directly reduce cancer growth by triggering phosphorylation of 5′ AMP-activated protein kinase (AMPk).(10-12) How metformin activates this energy sensor pathway is not fully understood.”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 2×
“Accordingly, these data extend to the xenograft model of triplenegative breast cancer our previous observations in cell cultures of non-small cell lung carcinoma(19) and document the relevance of direct action on cancer metabolism in anticancer potential of chronic metformin treatment reported in the clinical setting.…”
BackgroundResultOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“Actually, it selectively inhibits respiratory chain complex I, resulting in ATP depletion.(13,14) However, the consequences of mitochondrial impairment should be of limited relevance in cancer in which the fraction of ATP produced by glycolysis is more than 50 times higher than in normal tissues.”
BackgroundCellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · cited 1×
“Actually, it selectively inhibits respiratory chain complex I, resulting in ATP depletion.(13,14) However, the consequences of mitochondrial impairment should be of limited relevance in cancer in which the fraction of ATP produced by glycolysis is more than 50 times higher than in normal tissues.”
BackgroundMolecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
Wilson, J. E. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00241 · Cited by 1,085 · cited 5×
“Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet.”
BackgroundMethodInfluentialMetformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Cited by
A fully organic retinal prosthesis restores vision in a rat model of degenerative blindness
Maya-Vetencourt, J. F., Ghezzi, D., Antognazza, M. R., Colombo, E., Mete, M., Feyen, P., Desii, A., Buschiazzo, A., Di Paolo, M., Di Marco, S., et al. (2017) · Nature Materials · doi:10.1038/nmat4874 · Cited by 290
Self-citationRepurposing metformin: an old drug with new tricks in its binding pockets
Pryor, R., & Cabreiro, F. (2015) · Biochemical Journal · doi:10.1042/bj20150497 · Cited by 280
Zordoky, B. N. M., Bark, D., Soltys, C. L., Sung, M. M., & Dyck, J. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.023 · Cited by 98
Shiridokht, F., Dadashi, H., Vandghanooni, S., Eskandani, M., & Farajollahi, A. (2025) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2024.114220 · Cited by 30
Metadata
- Authors
- Marini, C., Salani, B., Massollo, M., Amaro, A., Esposito, A. I., Maria Orengo, A., Capitanio, S., Emionite, L., Riondato, M., Bottoni, G., Massara, C., Boccardo, S., Fabbi, M., Campi, C., Ravera, S., Angelini, G., Morbelli, S., Cilli, M., Cordera, R., Truini, M., Maggi, D., Pfeffer, U., & Sambuceti, G.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2013-11-15
- Volume
- 12
- Issue
- 22
- Pages
- 3490-3499
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2147917643
- Cited by
- 146
- References
- 14
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. https://app.cochat.ai/papers/10.4161/cc.26461
- The paper
- Marini, C., Salani, B., Massollo, M., Amaro, A., Esposito, A. I., Maria Orengo, A., Capitanio, S., Emionite, L., Riondato, M., Bottoni, G., Massara, C., Boccardo, S., Fabbi, M., Campi, C., Ravera, S., Angelini, G., Morbelli, S., Cilli, M., Cordera, R., . . . Sambuceti, G. (2013). Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. Cell Cycle. https://doi.org/10.4161/cc.26461
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.